Condition 1: Nausea and vomiting. Condition 2: female breast cancer. Condition 3: breast cancer. Condition 4: citrus medica. Nausea and vomiting Malignant neoplasm of central portion of breast Intraductal carcinoma in situ of breast
Conditions
Interventions
Intervention 1: Intervention group: People Suffering from Nausea and Vomiting Caused by Breast Cancer Chemotherapy, Who Receive One Tablespoon (10 Grams) Of Citrus Medica Paste Half an Hour Before Bre
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Women Aged 18 Years And Older Who Have Breast Cancer Definitive Diagnosis Of Breast Cancer With The Opinion Of Hemato-Oncologist And Pathologist History Of Receiving At Least One Course Of Chemotherapy Due To Breast Cancer History Of Experiencing Nausea Or Vomiting Following Chemotherapy Sessions Not Receiving Anti-Nausea And Vomiting Medicine In The Last 24 Hours Not Having A History Of Nausea And Vomiting Due To Reasons Other Than Chemotherapy (Such As High Blood Pressure, Kidney Failure, Liver And Digestive Problems Causing Nausea) Absence Of Hepatitis, Gastrointestinal Obstruction, Brain Malignancies Or Brain Metastases Absence Of Allergy To Citron
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CINV score in INVR questionnaire. Timepoint: Each Patient Is Evaluated Six Times (One Hour Before Chemotherapy, 12 Hours After Chemotherapy and On the Second, Third, Fourth and Fifth Days After Chemotherapy). Method of measurement: INVR questionnaire.;CINV score in VAS questionnaire. Timepoint: Each Patient Is Evaluated Six Times (One Hour Before Chemotherapy, 12 Hours After Chemotherapy and On the Second, Third, Fourth and Fifth Days After Chemotherapy). Method of measurement: VAS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Peyman Khamechi
Tehran University of Medical Sciences
Outcome results
None listed